GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Psyence Biomedical Ltd (NAS:PBM) » Definitions » Goodwill-to-Asset

Psyence Biomedical (Psyence Biomedical) Goodwill-to-Asset : 0.00 (As of Mar. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Psyence Biomedical Goodwill-to-Asset?

Goodwill to Asset ratio measures how much goodwill a company is recording compared to the total level of its assets. Psyence Biomedical's Goodwill for the quarter that ended in Mar. 2023 was $0.00 Mil. Psyence Biomedical's Total Assets for the quarter that ended in Mar. 2023 was $1.57 Mil.


Psyence Biomedical Goodwill-to-Asset Historical Data

The historical data trend for Psyence Biomedical's Goodwill-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psyence Biomedical Goodwill-to-Asset Chart

Psyence Biomedical Annual Data
Trend Mar21 Mar22 Mar23
Goodwill-to-Asset
- - -

Psyence Biomedical Semi-Annual Data
Mar21 Mar22 Mar23
Goodwill-to-Asset - - -

Competitive Comparison of Psyence Biomedical's Goodwill-to-Asset

For the Biotechnology subindustry, Psyence Biomedical's Goodwill-to-Asset, along with its competitors' market caps and Goodwill-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Psyence Biomedical's Goodwill-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Psyence Biomedical's Goodwill-to-Asset distribution charts can be found below:

* The bar in red indicates where Psyence Biomedical's Goodwill-to-Asset falls into.



Psyence Biomedical Goodwill-to-Asset Calculation

Goodwill to Asset ratio measures how much goodwill a company is recording compared to the total level of its assets.

It is calculated by dividing goodwill by total assets.

Psyence Biomedical's Goodwill to Asset Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Goodwill to Asset (A: Mar. 2023 )=Goodwill/Total Assets
=0/1.573
=

Psyence Biomedical's Goodwill to Asset Ratio for the quarter that ended in Mar. 2023 is calculated as

Goodwill to Asset (Q: Mar. 2023 )=Goodwill/Total Assets
=0/1.573
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Psyence Biomedical  (NAS:PBM) Goodwill-to-Asset Explanation

If the goodwill-to-asset ratio increases, it can mean that the company is recording a proportionately higher amount of goodwill, assuming total assets are remaining constant. It is generally good to see a company increasing its assets regularly; however, if these increases are coming from intangible assets, such as goodwill, the increases may not be as good.

Increases in the goodwill-to-asset ratio might suggest that a company has been aggressively acquiring other firms or has seen its tangible assets decrease in value. When a large portion of total assets are attributable to intangible assets (such as goodwill), the company may be at risk of having that portion of its asset base wiped out quickly if it must record any goodwill impairments. Decreases in the goodwill-to-assets ratio suggest that the company has either written down some goodwill or increased its tangible assets.

Asset needs vary from industry to industry. This is why comparing goodwill-to-assets ratios is generally most meaningful among companies within the same industry. By comparing a company's goodwill to assets ratio to those of other companies within the same industry, investors can get a feel for how a company is managing its goodwill.


Psyence Biomedical Goodwill-to-Asset Related Terms

Thank you for viewing the detailed overview of Psyence Biomedical's Goodwill-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Psyence Biomedical (Psyence Biomedical) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
121 Richmond Street West, Penthouse Suite 1300, Toronto, ON, CAN, M5H 2K1
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Psyence Biomedical (Psyence Biomedical) Headlines